Postgraduate Research Scholarship in Unstable RAAV Genome Elements

This postgraduate research scholarship is funded by New South Wales (NSW) Health and the University of Sydney as part of the NSW Health Gene and Cell Therapy PhD Program. The scholarship provides an opportunity for an outstanding PhD scholar to conduct research into developing a methodological infrastructure for research and quality management of unstable RAAV genome elements in support of clinical vector manufacturing. The successful recipient will receive a stipend allowance valued at $40,000 per annum for up to 3.5 years, subject to satisfactory academic performance. The scholarship recipient must be enrolled in a full-time PhD within the Faculty of Medicine and Health at the University of Sydney. The research focuses on developing methodologies critical to clinical vector manufacturing, specifically addressing the challenges of unstable recombinant adeno-associated virus (RAAV) genome elements. This work is essential for advancing gene and cell therapy applications in clinical settings.